Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This is a phase II placebo-controlled intervention trial assessing aspirin (ASA) as a UV protectant in patients at risk for melanoma.
Epistemonikos ID: 0f33cad1b121eabd95583132d439a2f3f3e8a7a3
First added on: May 22, 2024